Adjuvant checkpoint blockade following complete local therapy for melanoma metastases

被引:3
|
作者
Smithy, James W. [1 ]
Postow, Michael A. [1 ]
机构
[1] Mem Sloan Kettering Canc Ctr, Dept Med, Melanoma Serv, New York, NY 10065 USA
来源
LANCET | 2022年 / 400卷 / 10358期
基金
美国国家卫生研究院;
关键词
STAGE IV MELANOMA; DOUBLE-BLIND; IPILIMUMAB; NIVOLUMAB;
D O I
10.1016/S0140-6736(22)01748-2
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:1082 / 1083
页数:2
相关论文
共 50 条
  • [21] SKIN DENDRITIC CELLS IN MELANOMA ARE KEY FOR SUCCESSFUL CHECKPOINT BLOCKADE THERAPY
    Prokopi, N.
    Tripp, C. H.
    Tummers, B.
    Crawford, J. C.
    Efremova, M.
    Hutter, K.
    Bellmann, L.
    Cappellano, G.
    Boon, L.
    Ortner, D.
    Trajanoski, Z.
    Chen, S.
    de Gruijl, T.
    Green, D. R.
    Stoitzner, P.
    JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2020, 8 : A35 - A36
  • [22] Robust prediction of response to immune checkpoint blockade therapy in metastatic melanoma
    Auslander, Noam
    Zhang, Gao
    Lee, Joo Sang
    Frederick, Dennie T.
    Miao, Benchun
    Moll, Tabea
    Tian, Tian
    Wei, Zhi
    Madan, Sanna
    Sullivan, Ryan J.
    Boland, Genevieve
    Flaherty, Keith
    Herlyn, Meenhard
    Ruppin, Eytan
    NATURE MEDICINE, 2018, 24 (10) : 1545 - +
  • [23] Robust prediction of response to immune checkpoint blockade therapy in metastatic melanoma
    Noam Auslander
    Gao Zhang
    Joo Sang Lee
    Dennie T. Frederick
    Benchun Miao
    Tabea Moll
    Tian Tian
    Zhi Wei
    Sanna Madan
    Ryan J. Sullivan
    Genevieve Boland
    Keith Flaherty
    Meenhard Herlyn
    Eytan Ruppin
    Nature Medicine, 2018, 24 : 1545 - 1549
  • [24] Intraepithelial Melanoma in the Stomach After Treatment With Immune Checkpoint Blockade Therapy
    Shustef, Elina
    Torres-Cabala, Carlos A.
    Curry, Jonathan L.
    Tetzlaff, Michael T.
    Nagarajan, Priyadharsini
    Ivan, Doina
    Prieto, Victor G.
    Aung, Phyu P.
    AMERICAN JOURNAL OF DERMATOPATHOLOGY, 2017, 39 (08) : E116 - E118
  • [25] Radiation and checkpoint Blockade in the treatment of metastases
    Hirschmann, E.
    Gaipl, U. S.
    Fietkau, R.
    Distel, L.
    Hechtuk, M.
    ONCOLOGY RESEARCH AND TREATMENT, 2018, 41 : 189 - 189
  • [26] Single or dual immune checkpoint inhibitor as adjuvant therapy in advanced melanoma
    Fukumoto, Takeshi
    Horita, Nobuyuki
    EUROPEAN JOURNAL OF CANCER, 2021, 147 : 140 - 141
  • [27] Outcomes of adjuvant immune checkpoint inhibitor therapy in melanoma: a retrospective study
    Sarah, Fieuws
    Margot, De Ridder
    Valerie, Baert
    Alexander, Decruyenaere
    Lieve, Brochez
    Sylvie, Rottey
    Celine, Jacobs
    Michael, Saerens
    ACTA CLINICA BELGICA, 2024, 79 (04) : 285 - 293
  • [28] Local and Intralesional Therapy of In-Transit Melanoma Metastases
    Testori, Alessandro
    Faries, Mark B.
    Thompson, John F.
    Pennacchioli, E.
    Deroose, Jan P.
    Van Geel, Albertus N.
    Verhoef, Cornelis
    Verrecchia, Francesco
    Soteldo, Javier
    JOURNAL OF SURGICAL ONCOLOGY, 2011, 104 (04) : 391 - 396
  • [29] Is earlier better for melanoma checkpoint blockade?
    Robert, Caroline
    NATURE MEDICINE, 2018, 24 (11) : 1645 - 1648
  • [30] Immunotherapy for melanoma: Checkpoint blockade combinations
    Wolchok, Jedd D.
    CANCER IMMUNOLOGY RESEARCH, 2022, 10 (01)